Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results

Giuseppe Salvaggio,Alessandro Furlan,Francesco Agnello,Giuseppe Cabibbo,Daniele Marin,Lydia Giannitrapani,Chiara Genco,Massimo Midiri,Roberto Lagalla,Giuseppe Brancatelli

Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results

2014

Giuseppe Salvaggio
Alessandro Furlan
Francesco Agnello
Giuseppe Cabibbo
Daniele Marin
Lydia Giannitrapani
Chiara Genco
Massimo Midiri
Roberto Lagalla
Giuseppe Brancatelli

Purpose This study was undertaken to compare response evaluation criteria in solid tumours (RECIST) 1.1 and modified RECIST (mRECIST) in patients with unresectable hepatocellular carcinoma (HCC) on sorafenib, and to describe HCC enhancement changes before and after sorafenib treatment.

Keywords:

Radiology
Hepatocellular carcinoma
Sorafenib
Medicine
after treatment
Neuroradiology
mr imaging
response assessment
in patient
enhanced ct

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations